MagBioSense
St Louis · Founded 2013
About MagBioSense
MagBiosense (LLC) is a private medical device company focused on the development of breakthrough diagnostic device & assays, offering laboratory-quality sensitivity and the rapid results and ease of use of a point-of-care system. The company’s core technology eliminates the need for additional steps in the detection process, thereby allowing a simple, one-step process in a point-of-care setting. Using high sensitivity detection of cardiac biomarkers, MagBiosense is initially focusing its development on rapid diagnosis and rule out of heart attack at the Emergency Department.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Grant (Dec 2015)
- Website: http://www.magbiosense.com/
- Phone: +1 (314)359-8672
Industries & Categories
Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/magbiosense-2617576 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.